These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7865677)

  • 1. Changes in clot deformability--a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarction.
    Scrutton MC; Ross-Murphy SB; Bennett GM; Stirling Y; Meade TW
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):719-23. PubMed ID: 7865677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.
    Francis CW; Connaghan DG; Scott WL; Marder VJ
    Circulation; 1987 Jun; 75(6):1170-7. PubMed ID: 3568326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
    Mannila MN; Eriksson P; Ericsson CG; Hamsten A; Silveira A
    Thromb Haemost; 2006 Mar; 95(3):420-7. PubMed ID: 16525568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction.
    Becatti M; Marcucci R; Bruschi G; Taddei N; Bani D; Gori AM; Giusti B; Gensini GF; Abbate R; Fiorillo C
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1355-61. PubMed ID: 24790138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis.
    Fatah K; Hamsten A; Blombäck B; Blombäck M
    Thromb Haemost; 1992 Aug; 68(2):130-5. PubMed ID: 1384157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
    Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
    Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The elastic modulus of fibrin clots and fibrinogen gels: the effect of fibronectin and dithiothreitol.
    Procyk R; King RG
    Biopolymers; 1990 Feb; 29(3):559-65. PubMed ID: 1970486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction.
    Paton LN; Mocatta TJ; Richards AM; Winterbourn CC
    Free Radic Biol Med; 2010 Jan; 48(2):223-9. PubMed ID: 19857568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties.
    Helms CC; Kapadia S; Gilmore AC; Lu Z; Basu S; Kim-Shapiro DB
    Blood Coagul Fibrinolysis; 2017 Jul; 28(5):356-364. PubMed ID: 27755019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic evaluation of factor XIIIa*-like enzyme activity in equine plasma as a potential therapeutic avenue for the inhibition of fibrinous tissue.
    Coyne CP; Smith JE; DeBowes RM
    Am J Vet Res; 1992 May; 53(5):695-705. PubMed ID: 1355954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation.
    Blombäck B; Carlsson K; Fatah K; Hessel B; Procyk R
    Thromb Res; 1994 Sep; 75(5):521-38. PubMed ID: 7992253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
    Liu CZ; Shih MH; Tsai PJ
    Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling of fibrin with low density lipoproteins.
    Skrzydlewski Z
    Acta Med Acad Sci Hung; 1976; 33(2):171-7. PubMed ID: 199019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age.
    Fatah K; Silveira A; Tornvall P; Karpe F; Blombäck M; Hamsten A
    Thromb Haemost; 1996 Oct; 76(4):535-40. PubMed ID: 8902992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry.
    Ogawa S; Szlam F; Bolliger D; Nishimura T; Chen EP; Tanaka KA
    Anesth Analg; 2012 Jul; 115(1):16-21. PubMed ID: 22467887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viscoelastic properties of plasma fibrin clots are similar in patients on rivaroxaban and vitamin K antagonists.
    Kopytek M; Zabczyk M; Natorska J; Siudut J; Malinowski KP; Ptaszek P; Glajcar A; Goralczyk T; Undas A
    J Physiol Pharmacol; 2019 Feb; 70(1):. PubMed ID: 31019123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.